Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
NIH Grants & Funding for Leukodystrophy | Kisho | Kisho
2 additional grants classified as “Other” (multi-disciplinary, infrastructure, etc.).
Funding by Fiscal Year
NIH fiscal year (Oct–Sep)
$6.3M
FY22
$7.7M
FY23
$8.0M
FY24
$8.7M
FY25
$3.1M
FY26
By Funding Mechanism
R01
16
R21
6
R33
4
F30
2
F31
2
K23
2
Funding Gap Analysis
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Leukodystrophy. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
81 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for leukodystrophy. Existing research activity suggests this may be a viable area for grant applications.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
33 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for leukodystrophy. Existing research activity suggests this may be a viable area for grant applications.
Adjacent Research(18 grants)
These grants mention Leukodystrophy as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Other(18)
OtherR61Completed
Discovery and validation of multi-omic plasma biomarkers for Adrenomyeloneuropathy
Fatemi, S. Ali et al.·HUGO W. MOSER RES INST KENNEDY KRIEGER·BALTIMORE, MD
